Penfluridol in the treatment of newly admitted schizophrenic patients in a brief therapy unit (original) (raw)

Penfluridol in the Maintenance Treatment of Schizophrenic Patients Newly Discharged from A Brief Therapy Unit

Guy Chouinard

The Journal of Clinical Pharmacology, 1977

View PDFchevron_right

Acute effects of neuroleptics on unmedicated schizophrenic patients and controls

salvador contreras

Biological Psychiatry, 1993

View PDFchevron_right

Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year

Steven Hirsch

BMJ, 1989

View PDFchevron_right

Pimozide in the treatment of newly admitted schizophrenic patients

Guy Chouinard

Psychopharmacology, 1982

View PDFchevron_right

Pharmacology of new antipsychotic drugs: Are they stabilizers of schizophrenic psychosis?

Michel Bourin

Drug News & Perspectives, 1998

View PDFchevron_right

Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo

Steven Hirsch

BMJ, 1973

View PDFchevron_right

Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial

Carlos Chacon

Comprehensive Psychiatry, 1980

View PDFchevron_right

Intermittent versus maintenance neuroleptic long-term treatment in Schizophrenia—2-year results of a German multicenter study

Prof. Michael Linden

Journal of Psychiatric Research, 1993

View PDFchevron_right

A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics

Mohan Singh

Psychopharmacology, 1975

View PDFchevron_right

The prolactin response in patients receiving neuroleptic therapy. The effect of fluphenazine decanoate

LUCIANA CARILLI

Progress in Neuro Psychopharmacology, 1981

View PDFchevron_right

Flupwenazine Decanoate in Acute and ~Ainten~Ce Therapy of Schizop~K~Nia

Massimo Carlo Mauri

1987

View PDFchevron_right

The Pharmacologic Treatment of Schizophrenia: A Progress Report

Ross Baldessarini

Schizophrenia Bulletin, 1983

View PDFchevron_right

Pharmacological treatment of hospitalised schizophrenic patients in Belgium

J. Peuskens

International Journal of Psychiatry in Clinical Practice, 2006

View PDFchevron_right

Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists

Myriam Zylberman

British Journal of Clinical Pharmacology, 2001

View PDFchevron_right

Fluphenazine decanoate in acute and maintenance therapy of schizophrenia

Massimo Carlo Mauri

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1987

View PDFchevron_right

REVIEW ARTICLE *Corresponding Author: Pharmacotherapy of Schizophrenia: Ploypharmacy Approaches

Shahin Akhondzadeh

2010

View PDFchevron_right

The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms

Michael Krausz

Comprehensive Psychiatry, 2000

View PDFchevron_right

Pharmacological Treatment of Schizophrenia

Jeffrey Lieberman

A Guide to Treatments that Work, 2007

View PDFchevron_right

Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out- patients

Steven Hirsch

The British Journal of Psychiatry, 1979

View PDFchevron_right

Rediscovery of penicillin of psychiatry: haloperidol decanoate

Nazan Aydın

Psychiatry and Clinical Psychopharmacology

View PDFchevron_right

Oral fluphenazine versus placebo for schizophrenia: a Cochrane systematic review of 40 years of randomised controlled trials

Muhammad Almerie

Revista Colombiana De Psiquiatria, 2007

View PDFchevron_right

Neuroleptic dose: A statistical model for analyzing historical trends

Renee Binder

Journal of Psychiatric Research, 1987

View PDFchevron_right

Treatment of acute schizophrenia with ultra-high-dose fluphenazine: A failure at shortening time on a crisis-intervention unit

Donald Klein

Comprehensive Psychiatry, 1975

View PDFchevron_right

Pharmacotherapy of Schizophrenia: Ploypharmacy Approaches

Shahin Akhondzadeh

Acta Medica Iranica, 2010

View PDFchevron_right

Important Issues in the Drug Treatment of Schizophrenia

Carl Kinard

Schizophrenia Bulletin, 1980

View PDFchevron_right

Pharmacologic Treatment of Patients Hospitalized With the Diagnosis of Schizoaffective Disorder

David Benedek

The Journal of Clinical Psychiatry, 2001

View PDFchevron_right

Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden

Adrián LLerena

British journal of clinical pharmacology, 1995

View PDFchevron_right

Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients

John Ohrvik

Psychopharmacology, 1990

View PDFchevron_right

Pharmacological approaches to the management of schizophrenia: 10 years on

Tim Lambert

Australasian Psychiatry, 2013

View PDFchevron_right

Neuroleptics: Effects on Neuropsychological Function in Chronic Schizophrenic Patients

Paul Appelbaum

Schizophrenia Bulletin, 1990

View PDFchevron_right